Immunodetection of methicillin-resistant Staphylococcus aureus (MRSA) by conventional methods employing mammalian immunoglobulins has unknown detection limits, and often yields false-positive results because of the presence of S. aureus protein A, which binds the Fc region of mammalian IgG. In this study, a new PBP2a-specific chicken IgY antibody was developed in inbred and conventional chickens, and used for the detection of MRSA using whole cell lysate samples. Our results showed that this chicken IgY antibody minimized the side effects of protein A. Moreover, enzymelinked immunosorbent assay and immunochromatography systems were used with a monoclonal and polyclonal anti-PBP2a IgY antibody, clearly differentiating MRSA from methicillin-sensitive S. aureus and other methicillin-sensitive Staphylococcus spp. The detection limit of the immunochromatography was 10 8 colony-forming units; therefore, 1 colony on an agar plate was adequate to distinguish MRSA from non-MRSA. The specificity and sensitivity of this assay were almost similar to that of a commercially available latex agglutination test; however, the procedure used in this study was less complicated. The entire detection procedure, including sample preparation, takes only 20 min and does not require special equipment. Therefore, the use of this IgY antibody as a new tool for the detection of MRSA is highly recommended.
INTRODUCTION
Methicillin-resistant Staphylococcus aureus (MRSA) has spread to become one of the most important nosocomial and community pathogens worldwide, with emphasis on its status as a serious health concern in the United States (1, 2) . Therefore, rapid detection of MRSA from medical specimens is a prerequisite to ensure appropriate therapy.
MRSA harbors the mecA gene that encodes the resistance-determining penicillin-binding protein (PBP) 2a. PBP2a has reduced affinity for b-lactam antibiotics (3) (4) (5) , resulting in resistance to most members of the b-lactam antimicrobial agents. Therefore, mecA or PBP2a are indispensable targets for MRSA detection.
Most of the routine methods for MRSA detection involve bacterial cell culture or gene amplification by realtime PCR, which requires several hours (6) (7) (8) . On the other hand, immunological detection of MRSA is also difficult, since S. aureus protein A strongly binds to the Fc region of mammalian immunoglobulins, such as those found in mice and rabbits. Furthermore, protein A production greatly varies among strains (9) , and the standardization of background reactions thus becomes difficult.
Chicken IgY, a counterpart of mammalian IgG, is produced in the serum and is exclusively transferred to the egg yolk (10) . A large amount of IgY (100-200 mg/egg) can be extracted at a low cost from the egg yolks of hens immunized via a simple procedure (11) . Many IgY-based applications are currently under development (12) (13) (14) (15) . This study focused on its lower reactivity with protein A since IgY lacks a structurally different Fc region (16) .
In the present study, a novel immunodetection system for MRSA using anti-PBP2a IgY antibody was developed. Similarly, an enzyme-linked immunosorbent assay (ELISA) and immunochromatography systems (lateral-flow assay) were constructed for the rapid identification of MRSA.
MATERIALS AND METHODS
Bacterial strains and culture conditions: Strains ATCC43300, COL, ATCC29213, and RN4220 were used as type strains. Clinical isolates and other reference strains of MRSA and methicillin-sensitive S. aureus Clinical isolates  MRSA  T1  ＋  II  ST5  sputum  2003  This study  T2  ＋  II  ST5  sputum  2003  This study  T3  ＋  II  ST5  nasal fluid  2003  This study  T4  ＋  II  ST764 (ST5 slv)  urine  2003  This study  T5  ＋  II  ST5  surgical wound  2003  This study  T6  ＋  II  ST89  otorrhea  2003  This study  T7  ＋  II  ST5  sputum  2003  This study  T8  ＋  II  ST5  otorrhea  2003  This 
ATCC, American Type Culture Collection; MLST, multilocus sequence typing; ST, sequence type; PVL, Panton-Valentine leukocidin; slv, single-locus variant; dlv, double-locus variant.
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(MSSA) are listed in Table 1 . For the characterization of strains, multilocus sequence typing (MLST) and SCCmec typing were performed according to a universally accepted protocol (17, 18) . ATCC43300 is a reference strain recommended by the Clinical and Laboratory Standards Institute as a quality control for oxacillin-salt agar screening test. Other strains used includes S. epidermidis ATCC12228 and clinical isolates 5-26 and 5-58, S. saprophyticus ATCC49907, S. hominis ATCC29885, S. lugdunensis ATCC49576, S. intermedius ATCC29663, S. sciuri ATCC29060, S. haemolyticus ATTC29970, and S. xylosus ATTC49148. In addition, various sequence-type strains (reference and clinical isolates) were used for detection by immunochromatography (Table 1) . Strain 3429DmecA is a mecA-defective mutant of MRSA 3429, which was created by a double crossover event using shuttle vector pYT1 as described below. Escherichia coli XL1-Blue was used as a host strain for gene manipulation and production of recombinant proteins. All strains were grown at 379 C in Luria-Bertani (LB) broth with agitation at 160 rpm. Colonies used in the immunochromatography assay were also grown on tryptic soy agar (Difco TM ; Becton Dickinson, Sparks, Md., USA) for 20 h. The E. coli/S. aureus shuttle vector, pYT1, was kindly provided by Dr. Ito, Juntendo University. Since pYT1 has a temperature-sensitive origin in S.
aureus, it was used as a gene-targeting vector. DNA manipulations: DNA cloning and transformation of E. coli were performed using standard techniques (19) . Restriction enzymes were purchased from New England Biolabs (Beverly, Mass., USA) and Takara (Ohtsu, Japan). Ligation was performed using Ligation Kit Version 2.1 (Takara). All restriction endonuclease digestions and ligations were performed according to the manufacturer's instructions. Purification of plasmids and digestion of fragments were performed using QIAprep Spin Miniprep and QIAquick Gel Extraction kits (Qiagen, Hilden, Germany), respectively, according to the manufacturer's instructions.
Construction of the DmecA mutant: To obtain DmecA mutants, 2 DNA fragments of the mecA gene were individually amplified. The PCR primer sequences derived from the genome sequence of N315 were as follows: primer 1, 5?-CTCTAGATTCTAAAAGCGAT AATGG-3? and primer 2, 5?-GGAGCTCGGGACCA ACATAACCTAA-3? for the front-site fragment of mecA, and primer 3, 5?-CGGATCCACTGCTATCC ACCCTCAA-3? and primer 4, 5?-CGAAGCTTGAGA TTTTGGCATTGTAG-3? for the rear-site fragment of mecA. The reaction protocol for both fragments involved the use of a programed thermal cycler (GeneAmp TM 9700; Perkin Elmer Corp., Emeryville, Calif., USA) with a reaction consisting of 35 cycles of 949 C for 30 s, 559 C for 30 s, and 729 C for 1 min. The front-site fragment was digested with XbaI and SacI, and the rear-site fragment was digested with BamHI and HindIII. Each were then ligated into a corresponding site of pYT1, resulting in pYT1mecA. A 3429DmecA mutant was obtained by a double-crossover recombination and was verified by PCR and Southern blotting, as previously described (9) .
Preparation of anti-PBP2a antibodies: Polyclonal anti-PBP2a antibodies were prepared by immunizing chickens and rabbits with the recombinant protein.
Primers for recombinant PBP2a were as follows: 5?-CGGGATCCTATGCTTCCAAAGATAAAGA-3? and 5?-TGGATCCGCTTCACTGTTTTGTTATTC-3?. Genomic DNA of MRSA 3429 was used as a template for PCR, and the sequence of its mecA gene had 100z homology to strain N315. Amplified DNA fragments digested with BamHI were subcloned into the pQE30 vector (Qiagen) and introduced into E. coli XL1-Blue. The His-tagged recombinant protein was purified from the cell lysate first through batch purification using Ni-NTA agarose (Qiagen), and secondary-column purification using HisTrap HP (GE Healthcare Bio-Sciences AB, Solona, Sweden), according to the manufacturer's instructions. The purified recombinant protein (200 mg) was emulsified with an equal volume of Freund's complete adjuvant (Sigma-Aldrich, St. Louis, Mo., USA) and subcutaneously injected into chickens and rabbits. Inbred chickens used in this study belonged to genetically refined species (inbred line names: WL-F, GSP, and BL-E) (20) and were kindly provided by the Avian Bioscience Research Center of Nagoya University Graduate School of Bioagricultural Sciences. Japanese White rabbits were purchased from Japan SLC (Shizuoka, Japan). A booster with 200 mg of the recombinant protein was hypodermically injected at 2-week intervals for chickens and at 4-week intervals for rabbits; sera samples were subsequently obtained. Chicken IgY was purified from the egg yolk by an EGGstract IgY Purification System (Promega, Madison, Wis., USA). AntiPBP2a chicken IgY antibodies were obtained by affinity chromatography of recombinant PBP2a with AffiGel10/15 (Bio-Rad, Hercules, Calif., USA), and then conjugated with horseradish peroxidase (HRP) using Peroxidase Labeling Kit-NH 2 (Dojindo, Japan). Chicken monoclonal antibody-producing cells were established through immunization of non-inbred White Leghorn chickens against recombinant PBP2a and cell fusion with the chicken B cell line (21) at Medical and Biological Laboratories (MBL, Nagoya, Japan). The monoclonal antibody was obtained through hybridoma cultivation and affinity chromatography.
Western blot analysis: Overnight cultures of MRSA and MSSA were harvested and treated with 100 U/ml lysostaphin (Sigma, St. Louis, Mo., USA), 10 mM MgCl 2 , 10 mg/ml DNase I, and 10 mg/ml RNase A in PBS (pH 7.4). Lysates were separated by SDSpolyacrylamide gel electrophoresis and transferred to a ProBlott TM membrane (Applied Biosystems, Foster City, Calif., USA). PBP2a was detected with HRP-conjugated anti-PBP2a polyclonal IgY or with rabbit antiPBP2a antiserum followed by HRP-conjugated antirabbit IgG (MBL). Immunoreactive bands were visualized with 4-chloro-1-naphthol substrate (Sigma).
ELISA: A 96-well microplate was coated with the polyclonal capture anti-PBP2a IgY antibody obtained by affinity chromatography at 0.01 mg/ml in 50 mM carbonate buffer (pH 9.5), and then blocked with 0.5z gelatin. Bacteria were cultured to 1.0 OD 660 . The bacterial cell were enumerated as colony-forming units (CFU). Cells harvested by centrifugation were adjusted to 1.0 × 10 9 CFU/ml in 0.1 N NaOH for 5 min at room temperature for lysis, and then neutralized with an equal volume of 0.3 M phosphate buffer (pH 6.0). Treated bacterial cells (100 ml) were directly applied to the antibody-coated microplate. After 2 h of incubation at room temperature, the microplate was washed with PBS supplemented with 0.05z Tween-20. The HRPconjugated detection antibody was then applied and incubated for 2 h at room temperature. As a substrate, 3,3?,5,5?-tetramethylbenzidine was used (Dako, Glostrup, Denmark), and the absorbance at 450 nm was measured. The detection limit was evaluated with bacterial cells, using densities ranging from 1.0 × 10 8 to 1.0 × 10 3 CFU/well. The cross reactivity of anti-PBP2a antibody to MSSA and other staphylococci was evaluated using higher doses of bacterial lysates (1.0 × 10 9 CFU/well). Raw data of the absorbance of each ELISA plate were normalized using an identical sample as a standard to accommodate the total data.
Immunochromatography assay (lateral-flow assay): Polyclonal capture anti-PBP2a IgY (test line) and goat anti-chicken IgY antibodies (control line) were lined on a membrane of strips for lateral-flow immunochromatography. Gold colloid-conjugated monoclonal antiPBP2a IgY were fixed in an upstream conjugate pad (Nippon Gene, Toyama, Japan). Bacterial cells treated with the same procedure for ELISA were loaded on a strip and visually evaluated after 10 min. When using bacterial colonies on LB and tryptic soy agar, 1 colony was directly suspended in 50 ml of 0.1 N NaOH for 5 min, and then neutralized with an equal volume of 0.3 M phosphate buffer, as previously described.
Comparative study with latex agglutination test: A commercially available PBP2a detection assay MRSA-LA (Denka Seiken, Tokyo, Japan), which is a latex agglutination test, was performed according to the manufacturer's instructions.
RESULTS

Specificity of anti-PBP2a
IgY antibody compared to rabbit IgG antibody: Western blotting was performed for whole cell lysates of MRSA COL, MRSA 3429, MSSA RN4220, and 3429DmecA (MSSA) (Fig. 1) . A band corresponding to PBP2a (indicated by the arrow) was observed in both MRSA COL and MRSA 3429; however, this band was not seen in either MSSA RN4220 or 3429DmecA. When rabbit anti-PBP2a antiserum was used, broad bands corresponding to protein A were observed, with an especially strong band in RN4220 (lane A3). On the other hand, no protein Arelated bands were observed when chicken IgY antiPBP2a antibody was used.
Detection of MRSA by ELISA: An ELISA developed in the present study was used to detect MRSA COL in a dose-dependent manner from 1.0 × 10 8 to 1.0 × 10 5 CFU/well, with a detection limit at 1.0 × 10 6 CFU/well , and clinical isolates  (T1, T2, T3, T4, T5, T6, T7, T8, T9 , and T10); MSSA strains: RN4220, ATCC29213, and clinical isolates (S1, S2, S3, and S4); and other Staphylococcus spp.: S. epidermidis ATCC12228, clinical isolates (5-26 and 5-58), S. hominis ATCC29885, S. lugdunensis ATCC49576, S. intermedius ATCC29663, S. sciuri ATCC29060, S. haemolyticus ATTC29970, S. xylosus ATTC49148, and S. saprophyticus ATCC49907. Multiple assays using several plates were normalized by the identical COL sample, as described in Materials and Methods. Values represent the mean ± SD [error bars] of 3 independent assays. 
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(data not shown). As shown in Fig. 2 , all strains of MRSA produced much higher reactivities than the MSSA strains and other staphylococci tested. The reactivities of these non-MRSA strains were at background levels, even in case of MSSA RN4220, which produces copious amounts of protein A, as shown in Fig. 1 .
Immunochromatography assay (lateral-flow assay): Control lines were observed for both MRSA and MSSA. When the MRSA cell lysate was loaded, a red test line (positive reaction) was observed in a dosedependent manner after 10 min; however, none of the MSSA strains gave a positive reaction at any dose (Fig.  3A) . The minimum amount of bacterial cells needed to produce the test line was 10 8 in case of the MRSA COL strain. Therefore, this method allowed immediate identification of MRSA from a single colony grown on tryptic soy agar and LB agar. Not only colonies of SCCmec type II strains, but SCCmec type IV strains with various sequence-types also gave positive test lines. Colonies of MSSA and other tested staphylococcal species listed in the Materials and Methods section produced negative results (Figs. 3B and 3C) .
A comparative study: MRSA-LA, a latex agglutination test for PBP2a, gave positive results for all MRSA strains and negative results for all MSSA strains (data not shown).
DISCUSSION
This study prepared specific anti-PBP2a chicken IgY antibodies and developed novel immunological detection systems, including both ELISA and an immunochromatography assay for MRSA using whole cells. The specificity and sensitivity of these assays were almost equal to that of a commercially available latex agglutination test. The entire detection procedure developed here, including sample preparation, took only 20 min and did not require any additional equipment. The commercially available latex agglutination test must strictly be performed according to the manufacturer's instructions, with respect to cell density and heating times. In contrast, the immunochromatography assay developed here is applicable over a wider range of cell density (10 8 -10 9 CFU) and is easier to use and evaluate. This assay could detect various sequence-type MRSA strains, including healthcare-associated MRSA (HA-MRSA) type strains and community-associated MRSA (CA-MRSA) type strains. Among the tested CA-MRSA strains, 2004N237 produced a weak test line, and was mildly resistant to b-lactam antibiotics. These data imply that MRSA strains that produce little to no PBP2a may fail to be detected by immunochromatography because the detection of PBP2a protein is the principle of this system. After selecting a colony that appeared similar to S. aureus on the agar plate, identifying whether it was MRSA could be done as quickly as possible using the immunochromatography assay. Induction of PBP2a expression with b-lactam antibiotics may be useful for borderline strains in our system because the intensities of the test-line by strains with SCCmec type-IV became deeper after they were induced with ampicillin (data not shown). In case of strains with low-level resistance, it is often difficult to determine because of the borderline inhibitory zone diameter used as a criterion in disc testing. Therefore, it would be beneficial to use peripheral cells around the inhibitory zone with a disc containing b-lactam antibiotics.
We speculate that this system can be incorporated into an automated apparatus; although, threshold setting will be required. Anti-PBP2a chicken IgY enabled MRSA cells to be differentiated from MSSA cells at 10 6 CFU in ELISA and at 10 8 CFU in immunochromatography under present conditions. The current sensitivity seems to be sufficient for some infections. For example, it could be applicable for the immediate detection of MRSA in blood cultures in our preliminary tests, since bacterial growth in blood culture can reach about 10 9 CFU/ml, and this test requires much less time than real-time PCR.
Immunochromatography is a very useful tool for the simple, rapid, and easy detection of pathogenic microorganisms and their antigens. As such, it has been adopted in many clinical tests for infectious diseases. For instance, immunochromatographic method for detection of PBP2a with IgG1 subclass mouse monoclonal antibodies was recently developed (22) . However, as described in another report (23) , mouse IgG1 monoclonal antibodies react with protein A and can be purified using protein A-sepharose. Therefore, it is concerning that the immunochromatography assay used in that study reacted with MSSA strains due to protein A, which would further complicate the detection of MRSA when applied to whole cells.
Methicillin-resistant coagulase-negative staphylococci (MRCNS) also possess the mecA gene. Therefore, some MRCNS strains were applied to the IgY-based immunochromatography assay. Preliminary results showed that, unlike MRSA, this system only identified some of the MRCNS strains (data not shown). Sequence analyses were performed on the mecA gene of 5 MRCNS strains, which showed faint lines by immunochromatography, and found that their PBP2a had 100z amino-acid sequence similarity to N315 PBP2a. Therefore, the monoclonal chicken IgY antibody prepared in this study possibly recognizes PBP2a from these strains. It is hypothesized that the cell lysis procedure applied for MRSA was not fully adequate for MRCNS. Alternatively, the expression of PBP2a in the MRCNS strains may be too low to be detected by this system. Further studies aimed at sensitivity improvement need to be undertaken with respect to MRCNS detection. This study includes fundamental data about the role of anti-PBP2a IgY in the detection of MRSA cells. These data imply that the involvement of IgY will expand applications for the immunodetection of MRSA, whose direct identification from clinical specimens has long been difficult. A thorough search, including further evaluation of MRCNS, and other microorganisms that can occupy the same niche as S. aureus, is warranted before approval for clinical use.
